University of Pretoria
Pretoria, Gauteng, South Africa
Purpose
to develop a neuroprotectant drug to be delivered to the mother during protracted labor and/or to the newborn after birth to lessen severity of morbidity associated birth asphyxia and resulting hypoxic ischemic encephalopathy
Division
Gender Equality
Date
March 2022
Region Served
GLOBAL
Committed amount
$1,145,443
Grant topic
Maternal, Newborn, Child Nutrition and Health
Duration (months)
49
Grantee location
Pretoria, Gauteng, South Africa
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.